Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
354
-
Total 13F shares, excl. options
-
71.2M
-
Shares change
-
+2.16M
-
Total reported value, excl. options
-
$10.8B
-
Value change
-
+$369M
-
Put/Call ratio
-
0.91
-
Number of buys
-
175
-
Number of sells
-
-168
-
Price
-
$151.95
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2019
457 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2019.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 354 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.2M shares
of 106M outstanding shares and own 67.38% of the company stock.
Largest 10 shareholders include FMR LLC (9.2M shares), VANGUARD GROUP INC (6.23M shares), BlackRock Inc. (3.92M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.9M shares), SANDS CAPITAL MANAGEMENT, LLC (3.53M shares), JANUS HENDERSON GROUP PLC (2.73M shares), Invesco Ltd. (1.79M shares), FIL Ltd (1.77M shares), Avoro Capital Advisors LLC (1.4M shares), and STATE STREET CORP (1.36M shares).
This table shows the top 354 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.